Koers Repligen Corporation
Aandelen
RGEN
US7599161095
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
165,7 USD | -1,31% | +5,48% | -7,86% |
Omzet 2024 * | 638 mln. 595 mln. | Omzet 2025 * | 739 mln. 689 mln. | Marktkapitalisatie | 9,25 mld. 8,62 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 43 mln. 40,09 mln. | Nettowinst (verlies) 2025 * | 88 mln. 82,04 mln. | EV/omzet 2024 * | 14,1 x |
Nettoliquiditeiten 2024 * | 276 mln. 257 mln. | Nettoliquiditeiten 2025 * | 386 mln. 360 mln. | EV/omzet 2025 * | 12 x |
K/w-verhouding 2024 * |
313
x | K/w-verhouding 2025 * |
111
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 93,41% |
Recentste transcriptie over Repligen Corporation
1 dag | -1,31% | ||
1 week | +5,48% | ||
Lopende maand | -9,93% | ||
1 maand | -10,40% | ||
3 maanden | -10,70% | ||
6 maanden | +33,15% | ||
Lopend jaar | -7,86% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 01-05-14 |
Olivier Loeillot
PSD | President | 54 | 02-10-23 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 25-09-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 01-09-05 |
Director/Board Member | 58 | 12-06-14 | |
Martin Madaus
BRD | Director/Board Member | 64 | 06-02-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
2.43% | 5 M€ | -1,80% | - | |
1.01% | 0 M€ | 0,00% | - | |
0.84% | 0 M€ | 0,00% | - | |
0.55% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 165,7 | -1,31% | 238 746 |
24-04-24 | 167,9 | -2,00% | 545 959 |
23-04-24 | 171,3 | +8,76% | 928 614 |
22-04-24 | 157,5 | +0,22% | 294 448 |
19-04-24 | 157,1 | +0,05% | 386 770 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,86% | 9,37 mld. | |
-2,92% | 185 mld. | |
-3,80% | 107 mld. | |
-5,48% | 67,55 mld. | |
+11,22% | 54,6 mld. | |
+16,74% | 47,42 mld. | |
+2,13% | 42,24 mld. | |
+4,56% | 28,24 mld. | |
+1,64% | 26,42 mld. | |
+11,51% | 25,66 mld. |